A transmission puzzle may be getting clearer
Mpox may be spreading more often through people without symptoms than public health guidance previously assumed. That is the implication of a Kaiser Permanente study of nearly 8,000 men, which found that mpox in mid- to late 2024 was more common among men who have sex with men than earlier estimates suggested, with asymptomatic infections accounting for most of the cases detected in the study sample.
The work, published in Nature Communications, addresses a persistent epidemiological problem. During the 2022 global outbreak and its aftermath, many infections appeared to have no obvious connection to a symptomatic partner, even though prevailing assumptions held that people with visible symptoms were the main drivers of spread.
What the researchers found
To investigate, researchers tested rectal swabs originally collected for other sexually transmitted infection screening among men who have sex with men in Southern California during the summer and early fall of 2024. They then linked those findings to electronic health record monitoring for new mpox diagnoses in Kaiser Permanente Southern California.
The result was striking. Roughly 1% of the men tested had asymptomatic mpox infections, according to the supplied source text. The study’s senior author said the findings suggest infected people can pose a risk of transmitting the virus even in the absence of clinical symptoms.
If correct, that would help explain why many cases have lacked known ties to symptomatic exposure.
Why the findings matter
The study does not merely add another estimate of prevalence. It challenges a core practical assumption that has shaped how mpox risk is communicated. The U.S. Centers for Disease Control and Prevention has advised that people with symptoms drive transmission, but this dataset points to a more complex reality.
That matters for both surveillance and prevention. If symptom-free infections are common enough to contribute meaningfully to spread, case counts based only on clinical diagnosis may miss a larger reservoir of infection. Public health strategies that rely too heavily on visible symptoms could then undershoot the true pattern of transmission.
It also has implications for how clinicians and community health programs think about routine testing and risk communication in higher-incidence populations.
Caution and consequence
The supplied source does not claim that asymptomatic transmission is the only explanation for ongoing mpox spread, nor does it erase the importance of identifying and isolating symptomatic cases. But it does suggest that symptom-based models may be incomplete.
That has real-world consequences because mpox has continued to circulate despite vaccination availability. A clearer understanding of silent spread could help explain why the disease has proven harder to suppress than some early assumptions suggested.
The broader lesson is familiar from other outbreaks: when a pathogen can move through people who do not realize they are infected, public health systems lose one of their simplest detection tools. This study suggests mpox may fit that pattern more than previously understood.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
